Acyl‑CoA Profiling and Quantification

High‑Sensitivity Acyl‑CoA Profiling and Quantification Services for Metabolic Research, Drug Discovery, and Clinical Diagnostics

Acyl‑coenzyme A (acyl‑CoA) species are central intermediates in cellular metabolism, playing critical roles in energy production, lipid biosynthesis, protein acetylation, and the regulation of numerous metabolic pathways. The accurate quantification of individual acyl‑CoA species—from short‑chain acetyl‑CoA and malonyl‑CoA to medium‑ and long‑chain fatty acyl‑CoAs—is essential for understanding metabolic flux, identifying disease biomarkers, and evaluating the pharmacological effects of metabolic modulators. However, the analysis of acyl‑CoAs presents significant challenges due to their high polarity, labile thioester bond, low endogenous abundance, and poor ionisation efficiency, demanding highly specialised analytical methodologies. Our specialised detection platform offers a fully validated suite of analytical methods—including ultra‑high‑performance liquid chromatography‑tandem mass spectrometry (UHPLC‑MS/MS), isotope‑dilution mass spectrometry, and targeted metabolomics workflows—delivering unparalleled sensitivity, specificity, and quantitative accuracy. Whether the client is a pharmaceutical company, a clinical research organisation, or an academic laboratory, our service provides the precise, regulation‑ready data required to advance metabolic research, therapeutic development, and diagnostic innovation.

Scientific and Clinical Rationale for Acyl‑CoA Analysis

Clients seeking acyl‑CoA detection services are motivated by a range of critical objectives. In metabolic research and systems biology, the primary need is to quantify the levels of multiple acyl‑CoA species across different cellular compartments (cytosol, mitochondria, peroxisomes) to understand metabolic flux, substrate availability, and the regulation of key metabolic checkpoints. In drug discovery and development, acyl‑CoA profiling is essential for evaluating the on‑target and off‑target effects of compounds that modulate fatty acid oxidation, de novo lipogenesis, or mitochondrial function. In clinical diagnostics and biomarker discovery, altered acyl‑CoA levels in plasma, urine, or tissue biopsies serve as indicators of metabolic disorders, including fatty acid oxidation defects, mitochondrial diseases, and certain cancers. In nutritional and dietary research, measuring acyl‑CoA responses to fasting, feeding, or dietary interventions provides insights into energy homeostasis and metabolic flexibility. In quality control for biopharmaceuticals, acyl‑CoAs are sometimes used as reference standards or as cofactors in enzymatic reactions; their purity and concentration must be verified. Our service is architected to address these diverse requirements with a flexible, ISO 17025‑accredited analytical framework that adapts to the specific matrix (cell lysates, tissue homogenates, plasma, serum, mitochondrial fractions, fermentation broths) and the client's research or regulatory context.

Integrated Analytical Pipeline for High‑Fidelity Acyl‑CoA Profiling

Our analytical platform is organised into three interconnected modules that collectively ensure reliable and reproducible acyl‑CoA quantitation. The Sample Preparation Module employs optimised extraction and stabilisation protocols tailored to the matrix—including perchloric acid precipitation for cells and tissues, protein precipitation with acetonitrile for plasma, and solid‑phase extraction (SPE) using mixed‑mode sorbents for maximum recovery. To prevent degradation of the labile thioester bond, all procedures are performed at low temperature with rapid processing and the addition of stabilising agents (e.g., DTT, EDTA). We incorporate an isotopically labelled internal standard mixture (e.g., ¹³C₃‑acetyl‑CoA, ¹³C₂‑malonyl‑CoA, ¹³C₃‑palmitoyl‑CoA) at the earliest step to correct for extraction losses and matrix effects, achieving recoveries of 92–98% with relative standard deviations (RSD) < 3%. The Chromatographic and Detection Module uses ultra‑high‑performance liquid chromatography (UHPLC) with a C18 reversed‑phase column (1.7 µm) and a gradient mobile phase of aqueous ammonium acetate and acetonitrile, achieving baseline separation of up to 20 acyl‑CoA species (including acetyl‑CoA, malonyl‑CoA, succinyl‑CoA, propionyl‑CoA, and C4‑C18 fatty acyl‑CoAs) within a run time of 12 minutes. Detection is performed by tandem mass spectrometry (MS/MS) in positive electrospray ionisation (ESI) mode with multiple reaction monitoring (MRM) transitions, providing LOQs as low as 0.1 nM for short‑chain species and 0.5 nM for long‑chain species, with inter‑day precision < 4% RSD and accuracy of 95–105%. For absolute quantification, we use isotope dilution with matrix‑matched calibration to eliminate ion suppression effects. The Data Validation Module includes system suitability tests (retention time, peak symmetry, signal‑to‑noise ratio), quality control samples at low, medium, and high concentrations, and regular participation in inter‑laboratory proficiency testing to ensure ongoing accuracy. All methods are validated according to ICH Q2(R1) and FDA Bioanalytical Method Validation guidelines, and we provide full validation dossiers including specificity, linearity, accuracy, precision, LOD, LOQ, recovery, matrix effect, and stability.

Unmatched Sensitivity, Selectivity, and Metabolic Coverage

Our platform routinely delivers performance that surpasses regulatory and typical research requirements. The UHPLC‑MS/MS method provides a dynamic linear range spanning five orders of magnitude (0.1 nM to 10 µM), enabling the quantitation of both basal and stimulated acyl‑CoA levels in a single run. The MRM transitions are highly specific, with no detectable interference from isobaric compounds or endogenous matrix components. For more challenging matrices (e.g., fatty liver tissue or plasma with high lipid content), we employ hybrid SPE using a combination of reversed‑phase and ion‑exchange sorbents to further clean up the sample, achieving signal‑to‑noise ratios > 500:1 at the LOQ. In addition to the primary acyl‑CoA species, we can simultaneously quantify up to 25 related metabolites (including CoA‑SH, carnitine esters, and organic acids) in a single injection, providing a comprehensive snapshot of the cellular metabolic state. We also offer subcellular fractionation followed by acyl‑CoA measurement to distinguish mitochondrial from cytosolic and peroxisomal pools. Our automated sample handling and high‑throughput capability allow processing of up to 384 samples per day, making our service ideal for large‑scale screening or time‑course studies. This depth and breadth of analysis ensure that our clients receive not only a concentration value but also a rich metabolic context for their research.

Distinctive Advantages of Our Acyl‑CoA Detection Service

Our service offers several unique benefits that directly address client challenges. First, we provide customised method selection and development—clients can choose between our standard high‑throughput MS/MS assay, an ultra‑sensitive method for scarce samples (e.g., biopsy specimens), or a comprehensive targeted metabolomics panel that includes acyl‑CoAs alongside other key metabolites. Second, we maintain a comprehensive in‑house library of certified reference materials and stable isotope‑labelled internal standards for over 20 acyl‑CoA species, ensuring accurate quantification and reducing the burden on clients to source these reagents. Third, we offer a rapid turnaround service for urgent clinical or pharmacokinetic samples, with results available within 24 hours of sample receipt. Fourth, our stability studies evaluate the degradation of acyl‑CoAs under various storage and handling conditions (temperature, pH, freeze‑thaw, and sample processing), providing evidence‑based recommendations for sample collection and preservation. Fifth, we provide comprehensive data interpretation and statistical analysis, including comparison with control groups, fold‑change calculations, and multivariate visualisation (PCA, heatmaps) to help clients extract meaningful biological insights. Sixth, all our methods are accredited under ISO/IEC 17025 and comply with GLP guidelines, and we participate in international proficiency testing schemes (e.g., EQAS, FAPAS) to continuously verify our accuracy. Our team of metabolomics specialists and analytical chemists provides consultative support, assisting clients in experimental design, data interpretation, and troubleshooting.

Advanced Data Integration, Predictive Modeling, and Reporting

We understand that analytical data must inform scientific and clinical decision‑making. Our final reports are structured to deliver three levels of information: (i) a certificate of analysis (CoA) presenting the concentrations of each acyl‑CoA species (with measurement uncertainty) and a clear comparison to the client's specified reference range or acceptance criteria; (ii) a detailed analytical report containing raw chromatograms, calibration curves, quality control data, sample preparation details, and instrument parameters; and (iii) an interpretive summary that places the results in the context of the client's research objectives—for example, explaining how a significant change in the acetyl‑CoA/malonyl‑CoA ratio may indicate a shift in metabolic flux, or how an elevation in long‑chain acyl‑CoAs could reflect impaired fatty acid oxidation. For clients with multiple time‑points or treatment groups, we perform statistical analysis (t‑tests, ANOVA) and provide trend plots to visualise changes over time. We also offer predictive modeling of metabolic pathway activity based on acyl‑CoA profiles, using our internally developed algorithms. All raw data files (e.g., .raw, .csv, .dx) are supplied for full transparency and re‑analysis.

Broad Applications Across Drug Discovery, Clinical Research, and Nutrition

The versatility of our acyl‑CoA detection service makes it invaluable across multiple sectors. In drug discovery and pharmacology, our assays support target validation, mechanistic studies of metabolic modulators, and pharmacokinetic/pharmacodynamic evaluations. In clinical research and diagnostics, we quantify acyl‑CoAs in patient‑derived samples (plasma, urine, tissue biopsies) to explore their role as biomarkers for metabolic disorders, cardiovascular disease, and cancer. In nutrition and dietary intervention, our measurements inform studies on ketogenic diets, fasting, and exercise metabolism. In cell biology and biochemistry, we provide the precise data needed to study mitochondrial function, fatty acid oxidation, and lipogenesis. In industrial biotechnology, we monitor acyl‑CoAs in fermentation processes for the production of biofuels and biochemicals. Our ability to adapt the analytical approach to the specific matrix, scale, and regulatory environment ensures that we serve a diverse clientele with efficiency and expertise.

Commitment to Innovation, Quality, and Client Partnership

We are dedicated to maintaining leadership in acyl‑CoA analytics through continuous technological advancement and a culture of scientific excellence. Our current R&D includes the development of microfluidic chip‑based devices for near‑real‑time acyl‑CoA monitoring in live cell cultures, and the integration of machine learning algorithms to predict metabolic flux from multi‑analyte data. We actively participate in standardisation working groups (e.g., Metabolomics Standards Initiative) and contribute to the development of reference materials and best practices. Our quality management system is ISO 17025 and ISO 9001 certified, and we undergo regular external audits. We offer flexible service models—from single‑sample analysis to long‑term collaborative projects—with dedicated account management, volume‑based pricing, and priority handling for urgent requests. Our global logistics network provides sample kits with preservatives (e.g., trichloroacetic acid, EDTA) and clear instructions to ensure acyl‑CoA stability during transport. Turnaround times are typically 3–5 business days for standard MS/MS analysis and 5–7 business days for comprehensive profiling, with expedited options available. We maintain open, transparent communication, providing preliminary results upon request and final reports with full documentation. Our success is measured by the confidence our clients have in their data, enabling them to make sound scientific and commercial decisions. We invite you to partner with us for precise, reliable, and insightful acyl‑CoA detection services.

In summary, our acyl‑CoA detection service delivers a comprehensive, precise, and regulation‑ready analytical solution that combines state‑of‑the‑art UHPLC‑MS/MS, rigorous quality assurance, and expert interpretative support. By offering unmatched sensitivity, specificity, and adaptability across all relevant sample types, we empower our clients to advance metabolic research, accelerate drug development, and improve clinical diagnostics. We look forward to supporting your acyl‑CoA analysis needs with our unwavering commitment to quality.